Home/Filings/4/0001737287-25-000007
4//SEC Filing

Yoshiyama Annie 4

Accession 0001737287-25-000007

CIK 0001737287other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 8:14 PM ET

Size

310.9 KB

Accession

0001737287-25-000007

Insider Transaction Report

Form 4
Period: 2025-01-24
Yoshiyama Annie
SVP, Finance
Transactions
  • Award

    Common Stock

    2025-01-24+36,232137,990 total
  • Award

    Stock Option (Right to buy)

    2025-01-24+128,093128,093 total
    Exercise: $1.94Exp: 2035-01-24Common Stock (128,093 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001835208

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:14 PM ET
Size
310.9 KB